RVX-208 a Selective Bromodomain and Extra-terminal BET Protein Inhibitor Acts on Several Pathways to Benefit Cardiovascular Risks

被引：0
|
作者：
Wong, Norman C.
Kulikowski, Ewelina
Wasiak, Sylwia
Gilham, Dean
Halliday, Christopher
Lebioda, Kenneth
Sweeney, Mike
Johansson, Jan
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
Epigenetics; Inflammation; Complement HDL; Acute phase reactants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17127
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth
    Niu, Ningning
    Shao, Rui
    Yan, Guang
    Zou, Weiguo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (52) : 26647 - 26657
  • [22] Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor
    Hagihara, Shuichi
    Ishizawa, Kouhei
    Kikuchi, Manami
    Kawano, Yuko
    Nishidate, Akiko
    Matsumoto, Fumi
    Hashimoto, Naohiro
    Sasaki, Chiduko
    Miyaguchi, Ikuko
    Okada, Okimasa
    Akashi, Tomoya
    Nakayama, Shinji
    Ogasawara, Yuko
    Endo, Junichi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 109
  • [23] Selective BET inhibitor RVX-208 ameliorates periodontal inflammation and bone loss (vol 50, pg 1658, 2023)
    Sun, M.
    Clayton, N.
    Alam, S.
    Asmussen, N.
    Wong, A.
    Kim, J. H.
    Luong, G.
    Mokhtari, S.
    Pellei, D.
    Carrico, C. K.
    Schwartz, Z.
    Boyan, B. D.
    Giannobile, W., V
    Sahingur, S. E.
    Lin, Z.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2024, 51 (09) : 1256 - 1256
  • [24] Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor
    Zhao, Yujun
    Zhou, Bing
    Bai, Longchuan
    Liu, Liu
    Yang, Chao-Yie
    Meagher, Jennifer L.
    Stuckey, Jeanne A.
    McEachern, Donna
    Przybranowski, Sally
    Wang, Mi
    Ran, Xu
    Aguilar, Angelo
    Hu, Yang
    Kampf, Jeff W.
    Li, Xiaoqin
    Zhao, Ting
    Li, Siwei
    Wen, Bo
    Sun, Duxin
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) : 6110 - 6120
  • [25] APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS, IN MICE, AND IN CELL CULTURE SYSTEMS
    Gilham, Dean
    Tsujikawa, Laura
    Wasiak, Sylwia
    Jahagirdar, Ravi
    Fu, Li
    Ho, Phoebe
    Halliday, Christopher
    Sarsons, Christopher
    Stotz, Stephanie
    Rakai, Brooke
    Lebioda, Kenith
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman
    Kalantar-Zadeh, Kamyar
    Haarhaus, Mathias
    Kulikowski, Ewelina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 84 - 84
  • [26] BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients
    Wasiak, Sylwia
    Gilham, Dean
    Tsujikawa, Laura M.
    Halliday, Christopher
    Calosing, Cyrus
    Jahagirdar, Ravi
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C.
    Kulikowski, Ewelina
    MOLECULAR IMMUNOLOGY, 2017, 89 : 127 - 128
  • [27] Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
    Gallagher, Stuart J.
    Mijatov, Branka
    Gunatilake, Dilini
    Gowrishankar, Kavitha
    Tiffen, Jessamy
    James, Wilmott
    Jin, Lei
    Pupo, Gulietta
    Cullinane, Carleen
    McArthur, Grant A.
    Tummino, Peter J.
    Rizos, Helen
    Hersey, Peter
    PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (06) : 1126 - 1137
  • [28] EPIGENETIC BET READER INHIBITOR APABETALONE / RVX-208 COUNTERS PROFIBROTIC AND CONTRACTILE ACTIVITY OF CARDIAC FIBROBLASTS WITH POTENTIAL BENEFIT FOR HEART FAILURE
    Kulikowski, Ewelina
    Wasiak, Sylwia
    Tsujikawa, Laura
    Fu, Li
    Gilham, Dean
    Sarsons, Christopher
    Sweeney, Michael
    Johansson, Jan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 559 - 559
  • [29] Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
    Fu, Rong
    Zu, Shi-Jia
    Liu, Yan-Jun
    Li, Jia-Cheng
    Dang, Wen-Zhen
    Liao, Li-Ping
    Liu, Li-Ping
    Chen, Pan-Yu
    Huang, He-Ming
    Wu, Kang-Hui
    Zhou, Bing
    Pan, Qin
    Luo, Cheng
    Zhang, Yuan-Yuan
    Li, Guang-Ming
    BIOENGINEERED, 2022, 13 (04) : 10914 - 10930
  • [30] Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies
    Jiang, Fei
    Wei, Qingyun
    Li, Huili
    Li, Hongmei
    Cui, Yong
    Ma, Yu
    Chen, Haifang
    Cao, Peng
    Lu, Tao
    Chen, Yadong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (01)
12345